The Food and Drug Administration (FDA) has announced an opportunity for the public to comment on a proposed information collection related to establishment registration and product listing requirements for manufacturers of human blood, blood products, and licensed devices. This notice, part of the Paperwork Reduction Act of 1995, allows 60 days for public input. Comments can be submitted electronically via the Federal eRulemaking Portal or by mail, with detailed instructions provided by the FDA. The purpose of this information collection is to aid the FDA in inspecting facilities and ensuring the safety of the nation's blood supply.
Simple Explanation
The FDA wants to know what people think about some new rules for keeping track of who makes blood products and certain medical devices. This helps them check the places where these things are made to make sure everything is safe.